tiprankstipranks
Trending News
More News >
Impact BioMedical, Inc. (IBO)
:IBO
US Market

Impact BioMedical, Inc. (IBO) Stock Statistics & Valuation Metrics

Compare
61 Followers

Total Valuation

Impact BioMedical, Inc. has a market cap or net worth of ―. The enterprise value is ―.
Market Cap
Enterprise Value

Share Statistics

Impact BioMedical, Inc. has 12,085,412 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,085,412
Owned by Insiders11.89%
Owned by Institutions0.15%

Financial Efficiency

Impact BioMedical, Inc.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)
Return on Assets (ROA)
Return on Invested Capital (ROIC)
Return on Capital Employed (ROCE)
Revenue Per Employee
Profits Per Employee
Employee Count2
Asset Turnover
Inventory Turnover

Valuation Ratios

The current PE Ratio of Impact BioMedical, Inc. is ―. Impact BioMedical, Inc.’s PEG ratio is ―.
PE Ratio
PS Ratio0.00
PB Ratio
Price to Fair Value
Price to FCF
Price to Operating Cash Flow
PEG Ratio

Income Statement

In the last 12 months, Impact BioMedical, Inc. had revenue of ― and earned -4.41M in profits. Earnings per share was ―.
Revenue
Gross Profit
Operating Income-4.03M
Pretax Income
Net Income-4.41M
EBITDA-3.93M
Earnings Per Share (EPS)

Cash Flow

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow
Free Cash Flow
Free Cash Flow per Share

Dividends & Yields

Impact BioMedical, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta3.65
52-Week Price Change-78.54%
50-Day Moving Average0.63
200-Day Moving Average
Relative Strength Index (RSI)44.58
Average Volume (3m)7.14M

Important Dates

Impact BioMedical, Inc. upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date
Next Earnings Date
Ex-Dividend Date

Financial Position

Impact BioMedical, Inc. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio
Quick Ratio
Debt to Market Cap
Net Debt to EBITDA
Interest Coverage Ratio

Taxes

In the past 12 months, Impact BioMedical, Inc. has paid ― in taxes.
Income Tax
Effective Tax Rate

Enterprise Valuation

Impact BioMedical, Inc. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales
EV to EBITDA
EV to Free Cash Flow
EV to Operating Cash Flow

Balance Sheet

Impact BioMedical, Inc. has ― in cash and marketable securities with 8.01M in debt, giving a net cash position of ― billion.
Cash & Marketable Securities
Total Debt8.01M
Net Cash
Net Cash Per Share
Tangible Book Value Per Share

Margins

Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin
Operating Margin
Pretax Margin
Net Profit Margin
EBITDA Margin
EBIT Margin

Analyst Forecast

The average price target for Impact BioMedical, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis